Видео ютуба по тегу Jeffery Meyerhardt

Colorectal Cancer – An Introduction, with Jeffrey A. Meyerhardt, MD, MPH
Colorectal Cancer – An Introduction, with Jeffrey A. Meyerhardt, MD, MPH
Jeffrey Meyerhardt, MD, on how immunotherapies are being studied in gastric & esophageal cancers
Jeffrey Meyerhardt, MD, on how immunotherapies are being studied in gastric & esophageal cancers
Dr. Jeffrey Meyerhardt - Advances in the Treatment of Colorectal Cancer
Dr. Jeffrey Meyerhardt - Advances in the Treatment of Colorectal Cancer
Jeffrey A. Meyerhardt, MD, discusses immunotherapy in MSI-Stable CRC patients
Jeffrey A. Meyerhardt, MD, discusses immunotherapy in MSI-Stable CRC patients
Jeffrey A. Meyerhardt, MD, on managing 2nd and 3rd line mCRC patients
Jeffrey A. Meyerhardt, MD, on managing 2nd and 3rd line mCRC patients
Jeffrey A. Meyerhardt, MD, talks about the DFCI wellness study
Jeffrey A. Meyerhardt, MD, talks about the DFCI wellness study
Jeffrey A. Meyerhardt, MD, explains which molecular tests help determine treatment approach
Jeffrey A. Meyerhardt, MD, explains which molecular tests help determine treatment approach
Jeffrey A. Meyerhardt, MD explains integration of Stivarga and Lonserf in later lines of treatment
Jeffrey A. Meyerhardt, MD explains integration of Stivarga and Lonserf in later lines of treatment
Jeffrey Meyerhardt, MD, offers opinion on the effectiveness of SIRT in treatment of metastatic HCC
Jeffrey Meyerhardt, MD, offers opinion on the effectiveness of SIRT in treatment of metastatic HCC
Jeffrey A. Meyerhardt, MD, on whether regorafenib is becoming more tolerable for mCRC patients
Jeffrey A. Meyerhardt, MD, on whether regorafenib is becoming more tolerable for mCRC patients
Jeffrey A. Meyerhardt, MD, explains matching mutations and markers to therapies in CRC patients
Jeffrey A. Meyerhardt, MD, explains matching mutations and markers to therapies in CRC patients
Treatment of Localized Colorectal Cancer (CRC) — Jeffrey Meyerhardt, MD, MPH
Treatment of Localized Colorectal Cancer (CRC) — Jeffrey Meyerhardt, MD, MPH
Jeffrey Meyerhardt, MD, discusses BRAF+ mutation metastatic CRC and vemurafenib
Jeffrey Meyerhardt, MD, discusses BRAF+ mutation metastatic CRC and vemurafenib
Jeffrey A. Meyerhardt, MD, on genetic testing in newly diagnosed mCRC
Jeffrey A. Meyerhardt, MD, on genetic testing in newly diagnosed mCRC
Jeffrey A. Meyerhardt, MD, considers the BEACON study in BRAF mutated metastatic colorectal cancer
Jeffrey A. Meyerhardt, MD, considers the BEACON study in BRAF mutated metastatic colorectal cancer